Topoisomerase-I PS506 as a Dual Function Cancer Biomarker
Novel biomarkers for cancer diagnosis and therapy selection are urgently needed to facilitate early detection and improve therapy outcomes. We have previously identified a novel phosphorylation site at serine 506 (PS506) on topoisomerase-I (topo-I) and have shown that it is widely expressed in cell...
Main Authors: | Zhao, Ming, Gjerset, Ruth A. |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527781/ |
Similar Items
-
CK2-Mediated Hyperphosphorylation of Topoisomerase I Targets Serine 506, Enhances Topoisomerase I–DNA Binding, and Increases Cellular Camptothecin Sensitivity
by: Bandyopadhyay, Keya, et al.
Published: (2012) -
The p14ARF Alternate Reading Frame Protein Enhances DNA Binding of Topoisomerase I by Interacting with the Serine 506-Phosphorylated Core Domain
by: Bandyopadhyay, Keya, et al.
Published: (2013) -
Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets
by: Gilbert, D C, et al.
Published: (2012) -
Topoisomerase I as a Biomarker: Detection of Activity at the Single Molecule Level
by: Proszek, Joanna, et al.
Published: (2014) -
Dual Inhibitors Against Topoisomerases and Histone Deacetylases
by: Seo, Young Ho
Published: (2015)